JP Morgan Chase
OYST

JP Morgan Chase’s Oyster Point Pharma, Inc. Common Stock OYST Stock Holding History

JP Morgan Chase’s Portfolio OYST Stock Details OYST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-25,532
Closed -$285K – 7539
2022
Q4 		$285K Buy
25,532
+23,817
+1,389% +$231K ﹤0.01% 4855
2022
Q3 		$10K Buy
1,715
+719
+72% +$4.5K ﹤0.01% 5974
2022
Q2 		$4K Sell
996
-7,288
-88% -$41.4K ﹤0.01% 6227
2022
Q1 		$97K Buy
8,284
+1,720
+26% +$20.5K ﹤0.01% 5529
2021
Q4 		$120K Buy
6,564
+2,298
+54% +$29.2K ﹤0.01% 5600
2021
Q3 		$51K Hold
4,266
– – ﹤0.01% 5838
2021
Q2 		$73K Sell
4,266
-71,863
-94% -$1.37M ﹤0.01% 5637
2021
Q1 		$1.39M Buy
76,129
+48,041
+171% +$1.01M ﹤0.01% 3975
2020
Q4 		$528K Buy
28,088
+18,303
+187% +$395K ﹤0.01% 4335
2020
Q3 		$199K Sell
9,785
-5,583
-36% -$131K ﹤0.01% 4364
2020
Q2 		$444K Buy
15,368
+6,805
+79% +$205K ﹤0.01% 3904
2020
Q1 		$300K Buy
8,563
+1,133
+15% +$36.7K ﹤0.01% 4091
2019
Q4 		$182K Buy
+7,430
New +$130K ﹤0.01% 4710

Other funds holding OYST

HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

JP Morgan Chase's OYST Position: Q1 2023 in Review

JP Morgan Chase sold out of Oyster Point Pharma, Inc. Common Stock (OYST) in Q1 2023, closing a stake of 25,532 shares — an estimated $285K sold.

JP Morgan Chase first reported a position in OYST in Q4 2019 and held it in 13 quarters. The position peaked at $1.39M in Q1 2021. 1 fund tracked by Wall St. Rank holds OYST as of Q1 2023.

  • JP Morgan Chase reported no remaining Oyster Point Pharma, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • JP Morgan Chase sold 25,532 Oyster Point Pharma, Inc. Common Stock shares in Q1 2023, an estimated $285K.
  • JP Morgan Chase first reported a position in Oyster Point Pharma, Inc. Common Stock in Q4 2019 and held it in 13 quarters.
  • JP Morgan Chase's Oyster Point Pharma, Inc. Common Stock position peaked at $1.39M in Q1 2021.
  • 1 fund tracked by Wall St. Rank held Oyster Point Pharma, Inc. Common Stock as of Q1 2023.

Based on JP Morgan Chase's 13F filing for Q1 2023, filed 11 May 2023.